Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Grimm

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Inertial navigation system for bladder endoscopyAlexander Behrens, Jonathan Grimm, Sebastian Gross, et al.
World Journal of Hepatology|January 15, 2024
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis CGeorg Peschel, Kilian Weigand, Jonathan Grimm, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 19, 2022
Serum Galectin-3 in Hepatitis C Virus Infection Declines after Successful Virus Eradication by Direct-Acting Antiviral TherapyKilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Diagnostics (Basel, Switzerland)|November 24, 2020
Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver InjuryGeorg Peschel, Jonathan Grimm, Karsten Gülow, et al.
Journal of Clinical Medicine|April 30, 2021
Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral TherapyJonathan Grimm, Georg Peschel, Martina Müller, et al.
International Journal of Molecular Sciences|August 10, 2024
Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus ClearanceKilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Lipids in Health and Disease|October 25, 2022
Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infectionGeorg Peschel, Jonathan Grimm, Martina Müller, et al.
International Journal of Molecular Sciences|May 13, 2023
Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection-Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male PatientsGeorg Peschel, Kilian Weigand, Jonathan Grimm, et al.
International Journal of Molecular Sciences|January 23, 2024
Rising Lysophosphatidylcholine Levels Post-Hepatitis C ClearanceGeorg Peschel, Sabrina Krautbauer, Kilian Weigand, et al.
Biomedicines|December 23, 2022
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCVKilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Inertial navigation system for bladder endoscopyAlexander Behrens, Jonathan Grimm, Sebastian Gross, et al.
World Journal of Hepatology|January 15, 2024
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis CGeorg Peschel, Kilian Weigand, Jonathan Grimm, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 19, 2022
Serum Galectin-3 in Hepatitis C Virus Infection Declines after Successful Virus Eradication by Direct-Acting Antiviral TherapyKilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Diagnostics (Basel, Switzerland)|November 24, 2020
Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver InjuryGeorg Peschel, Jonathan Grimm, Karsten Gülow, et al.
Journal of Clinical Medicine|April 30, 2021
Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral TherapyJonathan Grimm, Georg Peschel, Martina Müller, et al.
International Journal of Molecular Sciences|August 10, 2024
Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus ClearanceKilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Lipids in Health and Disease|October 25, 2022
Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infectionGeorg Peschel, Jonathan Grimm, Martina Müller, et al.
International Journal of Molecular Sciences|May 13, 2023
Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection-Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male PatientsGeorg Peschel, Kilian Weigand, Jonathan Grimm, et al.
International Journal of Molecular Sciences|January 23, 2024
Rising Lysophosphatidylcholine Levels Post-Hepatitis C ClearanceGeorg Peschel, Sabrina Krautbauer, Kilian Weigand, et al.
Biomedicines|December 23, 2022
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCVKilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Pageof 3